Clear Filters Oppenheimer Fireside Chat on Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO, Valo Health CAIO and Social Impact Fund Founder May 5, 2023 Oppenheimer Fireside Chat on Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO, Valo Health CAIO and Social Impact Fund Founder Read More Part 1: Insights from Gain Therapeutics’ New CFO, Evan Ballantyne May 1, 2023 Part 1: Insights from Gain Therapeutics’ New CFO, Evan Ballantyne Read More MJFF announces a historic breakthrough in the development of Parkinson’s disease detection and diagnosis April 17, 2023 MJFF announces a historic breakthrough in the development of Parkinson’s disease detection and diagnosis Read More Oppenheimer Virtual Fireside Chat: Targeting the Undruggable – Latest Advances in AI Enabled Computational Biology and the future for Drug Discovery with Gain Therapeutics (GANX) CTO April 4, 2023 Oppenheimer Virtual Fireside Chat: Targeting the Undruggable – Latest Advances in AI Enabled Computational Biology and the future for Drug Discovery with Gain Therapeutics (GANX) CTO Read More Gain Therapeutics Unveils Star Compounds with Alzheimer’s Cell-Model Protection April 4, 2023 Gain Therapeutics Unveils Star Compounds with Alzheimer’s Cell-Model Protection Read More The Future of Computational Drug Discovery: AI Meets Biopharma April 2, 2023 The Future of Computational Drug Discovery: AI Meets Biopharma Read More Virtual Fireside Chat: Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO & Two Experts on Wednesday, March 29th at 12:00 p.m. EDT March 28, 2023 Virtual Fireside Chat: Computational Biology in Drug Discovery with Gain Therapeutics (GANX) CTO & Two Experts on Wednesday, March 29th at 12:00 p.m. EDT Read More SEE-Tx® Platform March 6, 2023 SEE-Tx® Platform Read More Lead Program in GBA-Parkinson’s Disease February 7, 2023 Lead Program in GBA-Parkinson’s Disease Read More Corporate Presentation August 2024 Corporate Presentation Download
